跳至主要内容
临床试验/ACTRN12623000594628
ACTRN12623000594628招募中2 期

Ketamine Sedation in Acute Traumatic Brain Injury in Adults: A randomized pilot feasibility study.

Alfred Health0 个研究点目标入组 40 人开始时间: 2023年5月31日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
Alfred Health
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • First admission to the intensive care unit (ICU) for management of moderate to severe traumatic brain injury with abnormal CT scan, Glasgow Coma Score <12 points and requirement from intracranial pressure monitoring
  • Clinically stable and sedated with an infusion of GABA agonist medication
  • Expected period of sedation >72hrs
  • For full active management

排除标准

  • Documented or suspected hypersensitivity to Ketamine
  • Known of suspected chronic kidney or liver disease
  • History of coronary artery disease or evidence of acute coronary syndrome
  • Admitted for palliative management
  • Greater than 72hrs elapsed since admission to the ICU

研究者

发起方
Alfred Health

相似试验

进行中(未招募)
1 期
The use of ketamine in acute brain injury patients.Traumatic Brain Injury patients requiring sedation to control the intracranial pressure (ICP).
EUCTR2017-004698-15-BEZ Leuven / KU Leuven100
进行中(未招募)
1 期
Brain Injury and Ketamine: a prospective, randomized controlled double blind clinical trial to study the effects of ketamine on therapy intensity level and intracranial pressure in acute brain injury patients.Traumatic brain injuryMedDRA version: 26.1Level: LLTClassification code: 10060690Term: Traumatic brain injury Class: 10022117
CTIS2023-505319-19-00Z Leuven100
撤回
不适用
Effects of acute ketamine administration on mental representations of the body in healthy participants.Mental Health - Studies of normal psychology, cognitive function and behaviourSchizophrenia
ACTRN12611000197932Prof. Mathew Martin-Iverson20
进行中(未招募)
1 期
Efficacy of ketamine in refractory convulsive status epilepticus in children: a multicenter, randomized, controlled, open-label, no-profit, with sequential design study.
EUCTR2013-004396-12-ITAzienda Ospedaliero-Universitaria Meyer57
进行中(未招募)
不适用
Ketamine as an alternative to electrocolvulsive therapy for treatment of major depressive disorderMajor depression disorderMedDRA version: 18.0Level: PTClassification code 10019063Term: HallucinationSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 18.0Level: PTClassification code 10013036Term: DiplopiaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 18.0Level: LLTClassification code 10061243Term: Post procedural nauseaSystem Organ Class: 100000004863MedDRA version: 18.0Level: PTClassification code 10047343Term: Vertigo CNS originSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.0Level: LLTClassification code 10015533Term: EuphoriaSystem Organ Class: 10037175 - Psychiatric disorders
EUCTR2011-001520-37-SESkåne University Hospital, Malmö